The microneedle drug delivery market size is USD 4.2 Bn in 2026.
The microneedle drug delivery market is projected to grow at a CAGR of 6% by 2033.
The microneedle drug delivery market growth drivers include painless administration, high skin permeability, improved patient compliance, and rising demand for biologics and vaccines.
North America is a dominating region for the microneedle drug delivery market.
3M Company, BD (Becton, Dickinson and Company), Pfizer Inc., Zosano Pharma Corporation, and Vaxxas Pty Ltd. are some leading industry players in the microneedle drug delivery market.